Literature DB >> 32358246

Critical Illness Neuropathy.

Hatice Tankisi1, Mamede de Carvalho2,3, Werner J Z'Graggen4.   

Abstract

Critical illness polyneuropathy (CIP) along with critical illness myopathy (CIM) is a frequent condition in critically ill patients. Similar to critical illness myopathy, the exact incidence, etiology, and mechanisms of CIP are not well understood. Although decreased compound muscle action potential amplitudes may be seen in both conditions, differentiation mostly relies on sensory nerve conduction studies which require special care to perform at intensive care units. In some instances, both CIP and critical illness myopathy are observed, and this condition is called critical illness neuromyopathy. In this review, nerve conduction studies and needle electromyography for the diagnosis of CIP and differentiation of CIP from critical illness myopathy and other conditions at intensive care units are summarized.

Entities:  

Mesh:

Year:  2020        PMID: 32358246     DOI: 10.1097/WNP.0000000000000658

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  3 in total

1.  Pathophysiology and management of critical illness polyneuropathy and myopathy.

Authors:  Kevin Cheung; Alasdair Rathbone; Michel Melanson; Jessica Trier; Benjamin R Ritsma; Matti D Allen
Journal:  J Appl Physiol (1985)       Date:  2021-03-18

2.  Neuromuscular involvement in COVID-19 critically ill patients.

Authors:  Lidia Cabañes-Martínez; Marta Villadóniga; Liliana González-Rodríguez; Lesly Araque; Alba Díaz-Cid; Ignacio Ruz-Caracuel; Héctor Pian; Susana Sánchez-Alonso; Samira Fanjul; Marta Del Álamo; Ignacio Regidor
Journal:  Clin Neurophysiol       Date:  2020-10-15       Impact factor: 3.708

3.  Correlations between Electro-Diagnostic Findings, the Severity of Initial Infection, and the Rehabilitation Outcomes among COVID-19 Patients.

Authors:  Sheer Shabat; Zeev Meiner; Jeanna Tsenter; Isabella Schwartz; Sigal Portnoy
Journal:  Biology (Basel)       Date:  2022-02-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.